infiltrating ductal and lobular carcinoma of breast drug therapy 2000:2010[pubdate] *count=100 - BioMedLib™ search engine
Carcinoma, Ductal, Breast / epidemiology. Carcinoma, Ductal, Breast / pathology. Carcinoma, Ductal, Breast / therapy. Carcinoma ... Carcinoma, Ductal, Breast / drug therapy. Carcinoma, Ductal, Breast / secondary. Carcinoma, Lobular / drug therapy. Carcinoma, ... Breast Neoplasms / surgery. Carcinoma, Ductal, Breast / radiotherapy. Carcinoma, Ductal, Breast / surgery. Carcinoma, Lobular ... MeSH-minor] Breast / pathology. Carcinoma / metabolism. Carcinoma, Ductal, Breast / diagnosis. Carcinoma, Ductal, Breast / ...http://www.bmlsearch.com/?kwr=infiltrating+ductal+and+lobular+carcinoma+of+breast+drug+therapy+2000:2010%5Bpubdate%5D&cxts=100&stmp=b1
A Case Report: Lobular Carcinoma In Situ in a Male Patient with Subsequent Invasive Ductal Carcinoma Identified on Screening...
Lobular Carcinoma In Situ in a Male Patient with Subsequent Invasive Ductal Carcinoma Identified on Screening Breast MRI Linda ... Lobular Carcinoma In Situ in a Male Patient with Subsequent Invasive Ductal Carcinoma Identified on Screening Breast MRI. J ... Lobular carcinoma in situ is a form of in situ neoplasia that develops within the terminal lobules of the breast. It is an ... Keywords: Lobular carcinoma in situ, male, breast cancer, MRI, screening and imaging ...http://jcancer.org/v03p0226
Gentaur Molecular :US Biomax \ High-density breast invasive ductal and lobular carcinoma tissue array with normal tissues,...
High-density breast invasive ductal and lobular carcinoma tissue array with normal tissues, grading and staging data,192 cases_ ... Breast cancer tissue microarray, containing 80 cases of each invasive ductal carcinoma and invasive lobular carcinoma, 32 ... High-density breast invasive ductal and lobular carcinoma tissue array with normal tissues, grading and staging data,192 cases_ ... High-density breast invasive ductal and lobular carcinoma tissue array with normal tissues, grading and staging data,192 cases_ ...http://www.antibody-antibodies.com/product_det.php?id=1970452&supplier=search&name=High_density%20breast%20invasive%20ductal%20and%20lobular%20carcinoma%20tissue%20array%20with%20normal%20tissues,%20grading%20and%20staging%20data,192%20cases_192%20cores%3B%20ihc%20%20Anti_Actin%20confirmed
Mammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive...
2002). Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast ... 2002). Apocrine differentiation in invasive pleomorphic lobular carcinoma with in situ ductal and lobular apocrine carcinoma: ... 2000). A comparison of cell cycle markers in well-differentiated lobular and ductal carcinomas. Breast Cancer Res. Treat. 61, ... 2004). Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Mol. Biol. Cell 15, 2523- ...http://dmm.biologists.org/content/4/3/347
Computer-aided-detection marker value and breast density in the detection of invasive lobular carcinoma | SpringerLink
Purpose Invasive Lobular Carcinoma (ILC) is frequently a mammographic and diagnostic dilemma; thus any additional information ... Li C, Anderson B, Daling J, Moe R (2003) Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA 289(11 ... Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res 6(3):R149-R156 ... Tot T (2003) The diffuse type of invasive lobular carcinoma of the breast: morphology and prognosis. Virchows Arch 443:718-724 ...https://link.springer.com/article/10.1007%2Fs11548-007-0074-8
MDM2 SNP309 Accelerates Tumor Formation in a Gender-Specific and Hormone-Dependent Manner | Cancer Research
Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA 2003; 289: 1421-4. ... Invasive ductal breast carcinoma. To test if the G-allele of SNP309 can indeed accelerate tumorigenesis only in the presence of ... Between April 2004 and October 2005, 258 Caucasian women previously diagnosed with infiltrating ductal carcinoma of the breast ... Abnormal expression of MDM-2 in breast carcinomas. Breast Cancer Res Treat 1996; 37: 179-88. ...http://cancerres.aacrjournals.org/content/66/10/5104?ijkey=4c20ba630b402a0ce858bb07b1a27812082a908e&keytype2=tf_ipsecsha
Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing...
Histologically confirmed HER2-negative primary invasive ductal or invasive lobular breast carcinoma. For patients enrolling for ... Breast Neoplasms. Neoplasms by Site. Neoplasms. Breast Diseases. Skin Diseases. Paclitaxel. Docetaxel. Liposomal doxorubicin. ... Breast Neoplasms Drug: Doxorubicin Biological: Trastuzumab Drug: Cyclophosphamide Drug: Paclitaxel Drug: Epirubicin Drug: ... A HER2-negative primary breast cancer sample from a patient eligible for randomization should have a HER2 IHC score of 0 or 1+ ...https://clinicaltrials.gov/ct2/show/NCT01779050
Therapy to Prevent Sexual Pain in Breast Cancer Survivors - Full Text View - ClinicalTrials.gov
Has a previous diagnosis of breast cancer (ductal or lobular carcinoma, invasive). ... Genetics Home Reference related topics: breast cancer MedlinePlus related topics: Breast Cancer Menopause Sexual Problems in ... Breast Neoplasms. Vulvodynia. Dyspareunia. Neoplasms by Site. Neoplasms. Breast Diseases. Skin Diseases. Vulvar Diseases. ... Vulvodynia Dyspareunia Breast Cancer Menopause Drug: Topical liquid lidocaine Drug: Topical saline Phase 3 ...https://clinicaltrials.gov/ct2/show/NCT01539317?recr=Open&cond=%22Vulvar+Diseases%22&rank=10
Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial - Full Text View -...
Atypical Ductal Breast Hyperplasia Lobular Carcinoma in Situ (LCIS) Atypical Lobular Hyperplasia (ALH) of Breast Drug: SOM 230 ... Carcinoma in Situ. Carcinoma, Lobular. Breast Carcinoma In Situ. Carcinoma, Intraductal, Noninfiltrating. Pathologic Processes ... Neoplasms, Ductal, Lobular, and Medullary. Breast Neoplasms. Neoplasms by Site. Breast Diseases. Skin Diseases. Pasireotide. ... Atypical Ductal Hyperplasia (ADH), Lobular Carcinoma in situ (LCIS), and/or Atypical Lobular Hyperplasia (ALH) ...https://clinicaltrials.gov/ct2/show/NCT01372644
Reversion of the Malignant Phenotype of Human Breast Cells in Three-Dimensional Culture and In Vivo by Integrin Blocking...
1994) Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 143:1731- ... Recapitulation of carcinoma in situ in axillary nodal breast carcinoma metastasis: clinical and biological implications. Breast ... 1995) Cellular growth and survival are mediated by β1 integrins in normal human breast epithelium but not in breast carcinoma. ... 1995) High expression level of α6 integrin in human breast carcinoma is correlated with reduced survival. Cancer Res 55:901-906 ...http://jcb.rupress.org/content/137/1/231
Patent US5991028 - Spectral bio-imaging methods for cell classification - Google Patents
In the evaluation of infiltrating breast carcinomas, ductal and lobular carcinomas may present similar histological appearances ... quantitive histopathologic variables in lobular carcinoma of the breast. Cancer 72:2602, 1993]. Both lobular and ductal types ... Nuclear structure and chromatin condensation in in situ and infiltrating ductal and lobular breast carcinoma were determined. ... Close to 80% of breast carcinomas are of the ductal type [Aaltomaa S, Lipponen P: Prognostic factors in breast cancer (reviews ...http://www.google.com/patents/US5991028?dq=5,894,079
Serum High-Density Lipoprotein Cholesterol and Breast Cancer Risk by Menopausal Status, Body Mass Index, and Hormonal Receptor...
All of the cases were newly and histologically diagnosed with invasive ductal or lobular carcinoma of breast. Among 1,453 ... Evaluation of the synergistic effect of insulin resistance and insulin-like growth factors on the risk of breast carcinoma. ... Serum lipids and outcome of early-stage breast cancer: results of a prospective cohort study. Breast Cancer Res Treat 2005;94: ... Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 1993;15:17-30. ...http://cebp.aacrjournals.org/content/18/2/508
Publications - UNC Carolina Population Center
Reproductive Risk Factor Associations with Lobular and Ductal Carcinoma in the Carolina Breast Cancer Study. Cancer Causes & ... Racial Differences in PAM50 Subtypes in the Carolina Breast Cancer Study. Journal of the National Cancer Institute, 110(2), ...http://www.cpc.unc.edu/cpc/research/publications?b_start:int=120
Publications - UNC Carolina Population Center
Reproductive Risk Factor Associations with Lobular and Ductal Carcinoma in the Carolina Breast Cancer Study. Cancer Causes & ... and Invasive Breast Cancer in the Carolina Breast Cancer Study. Journal of Women's Health. ... A Functionally Significant SNP in TP53 and Breast Cancer Risk in African-American Women. NPJ Breast Cancer, 3, 5. PMCID: ... 2017). Active Smoking and Survival following Breast Cancer among African American and Non-African American Women in the ...http://www.cpc.unc.edu/research/publications?form.b_start=0&form.searchabletext=olshan,+andrew&form.sort_on=ryat&form.actions.search=Search
Half of Breast Cancer Patients Pursue Reconstructive Surgery Without Understanding of Risks - UNM Comprehensive Cancer Center
All patients had stage I-III invasive ductal/lobular breast cancer, ductal carcinoma in situ (DCIS) or were having preventive ... "We found that less than half of the women had adequate medical knowledge about breast reconstruction and made a choice that ... Clara Lee, principal investigator of the study and a breast reconstructive surgeon at the OSUCCC - James. Lee holds a dual ... Half of Breast Cancer Patients Pursue Reconstructive Surgery Without Understanding of Risks. By ...http://cancer.unm.edu/2017/05/16/half-of-breast-cancer-patients-pursue-reconstructive-surgery-without-understanding-of-risks/
A Lesson on Breast Cancer by Dr. Peter W Kujtan - A Research Guide for Students
Kujtan points out that in Canada, about 70 women and one man start their battle with some form of breast cancer every single ... The most common type of breast cancers are ductal and lobular carcinoma. Ductal cancers begin in the milk ducts, while lobular ... Invasive ductal carcinomas are by far the most common type that we see. A rarer form of breast cancer is called Paget's Disease ... In the still rarer cases, breast cancer can arise from other structures within the breast such as blood vessels, lymphatics and ...https://www.bydewey.com/drkbcancer2.html
Flaxseed in Preventing Breast Cancer in Premenopausal Women at Risk of Developing Breast Cancer - Full Text View -...
breast cancer. atypical ductal breast hyperplasia. lobular breast carcinoma in situ. ductal breast carcinoma in situ. breast ... History of ductal carcinoma in situ. *Prior stage I breast cancer allowed provided it was adequately treated and therapy was ... History of atypical lobular hyperplasia or lobular carcinoma in situ with or without family history ... Flaxseed in Preventing Breast Cancer in Premenopausal Women at Risk of Developing Breast Cancer. The safety and scientific ...https://clinicaltrials.gov/ct2/show/study/NCT00794989?view=record
Microarray Profiling in Breast Cancer Patients | SpringerLink
The traditional prognostic and predictive factors in breast cancer ma ... Breast cancer is the most common cancer among women. It arises from a variety of genetic, epigenetic, and chromosomal ... Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Mol Biol Cell 2004;15:2523-2536. ... Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA ...https://link.springer.com/chapter/10.1007/978-1-60327-088-5_16
MedGen for PubMed (Select 18096313) - MedGen - NCBI
Breast carcinoma. A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common ... The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by ... lobular cancer). Most men have little or no lobular tissue, so lobular cancer in men is very rare.In its early stages, breast ... The vast majority of cases are carcinomas arising from the breast parenchyma or the nipple. Malignant breast neoplasms occur ...https://www.ncbi.nlm.nih.gov/medgen?LinkName=pubmed_medgen&from_uid=18096313
Cancerous tumours of the breast - Canadian Cancer Society
Malignant tumours of the breast are cancerous growths that have the potential to spread (metastasize) to other parts of the ... Ductal carcinoma and lobular carcinoma. Nearly all breast cancers are adenocarcinomas. These tumours start in gland cells. The ... most common adenocarcinomas of the breast are:* ductal carcinoma (including ductal carcinoma in situ, or DCIS), which starts in ... Rare breast tumours. The following cancerous tumours of the breast make up less than 1% of all breast cancers:* a type of non- ...http://www.cancer.ca/en/cancer-information/cancer-type/breast/breast-cancer/cancerous-tumours/?region=nl
Thioredoxin 1 as a serum marker for breast cancer and its use in combination with CEA or CA15-3 for improving the sensitivity...
Abbreviation used: F; Female, M; Male, BC; Breast Cancer, L; lobular carcinoma of breast cancer, D; ductal carcinoma of breast ... lobular carcinoma of breast; BCD; ductal carcinoma of breast; NF, normal female; I, II, III; grade 1, II, III of breast cancer ... 6.878 ng/mL in ductal carcinoma of breast (BCD). The serum Trx1 level in lobular carcinoma of breast was nearly same as that in ... pancreatic carcinoma, lung carcinoma and breast carcinoma, as well as individuals with medullary thyroid carcinoma, had higher ...https://bmcresnotes.biomedcentral.com/articles/10.1186/1756-0500-7-7
... Online Medical Reference - from definition and diagnosis through risk factors and treatments. Authored by Dr. ... The most common types of invasive breast cancer are infiltrating ductal carcinoma and infiltrating lobular carcinoma. Less ... Certain benign breast biopsy findings, including atypical hyperplasia and lobular carcinoma in situ, are also associated with ... Male Breast Cancer. Breast cancer in men is relatively uncommon. Treatment is similar to that of women with breast cancer with ...http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/hematology-oncology/breast-cancer/
Human NRG1 beta 1 ELISA Kit (ab100614) | Abcam
Not detected in breast carcinoma samples, including ductal, lobular, medullary, and mucinous histological types, neither in ... Isoform alpha is expressed in breast, ovary, testis, prostate, heart, skeletal muscle, lung, placenta liver, kidney, salivary ... is a soluble activating ligand for the ERBB2-ERBB3 receptor complex and acts as an autocrine growth factor in a specific breast ...https://www.abcam.com/human-nrg1-beta-1-elisa-kit-ab100614.html
Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38...
Brk signaling to p38 MAPK may characterize a subset (approximately 14 to 15%) of human ductal and lobular breast carcinoma. ... of invasive ductal breast carcinomas [6, 7], prostate and colon carcinomas [8, 9], 70% of serous ovarian carcinomas , 37.5 ... However, we detected Brk in 72.5% (29/40) of ductal carcinoma samples and 52.2% (24/46) of lobular carcinomas included in the ... normal breast), fibroadenoma, and infiltrating ductal or lobular carcinoma. Positively-stained sections were further scored for ...https://breast-cancer-research.biomedcentral.com/articles/10.1186/bcr2946
Multiple Functions of Sushi Domain Containing 2 (SUSD2) in Breast Tumorigenesis | Molecular Cancer Research
However, staining was observed in pathologic breast lesions and in lobular and ductal carcinomas. SUSD2 interacts with galectin ... Multiple Functions of Sushi Domain Containing 2 (SUSD2) in Breast Tumorigenesis. Allison P. Watson, Rick L. Evans and Kristi A. ... Multiple Functions of Sushi Domain Containing 2 (SUSD2) in Breast Tumorigenesis. Allison P. Watson, Rick L. Evans and Kristi A. ... Multiple Functions of Sushi Domain Containing 2 (SUSD2) in Breast Tumorigenesis. Allison P. Watson, Rick L. Evans and Kristi A. ...http://mcr.aacrjournals.org/content/early/2013/01/01/1541-7786.MCR-12-0501-T